The STUDIA UNIVERSITATIS BABEŞ-BOLYAI issue article summary

The summary of the selected article appears at the bottom of the page. In order to get back to the contents of the issue this article belongs to you have to access the link from the title. In order to see all the articles of the archive which have as author/co-author one of the authors mentioned below, you have to access the link from the author's name.

 
       
         
    STUDIA CHEMIA - Issue no. 1 / 2018  
         
  Article:   THE ASSESSMENT OF FLUOROPHORES ADVANCED GLYCATION END PRODUCTS-TO-KYNURENINE RATIO IN HEALTHY AND DIABETIC RATS AND HUMANS.

Authors:  LOREDANA ELENA OLAR, DANA MIHAELA CIOBANU, FLORICA MATEI, IONEL PAPUC.
 
       
         
  Abstract:  
DOI: 10.24193/subbchem.2018.1.03

Published Online: 2018-03-30
Published Print: 2018-03-30
pp. 37-53

VIEW PDF



ABSTRACT:In this study, we calculated the ratio of the serum contributions of two highly studied fluorophore products (advanced glycation end products - AGEs and kynurenine - KYN) in the area of nutrition and metabolic diseases including diabetes mellitus (DM), by using a non-invasive, economical and easy-to-perform method. Blood serum spectrofluorimetric analysis was performed both in the case of normoglycemic (n=10) and diabetic rats (n=10), and in the case of non-diabetic (n=14) and type 2 diabetes mellitus (T2DM) patients (n=52). Our results showed a significant increase in the contributions of the two products in diabetic patients and rats compared to the control group. The ratio of the two compounds was positively correlated with serum glucose levels in the case of rats, and with serum triglyceride values in the case of humans. Also, the presence of DM complications in human subjects and the subsequent calculation of ROC curves led to a predictive value of the investigated ratio (AGEs/KYN) for the presence of peripheral diabetic polyneuropathy (PNP). The obtained results suggest a high potential for the investigated ratio to be considered as a new biomarker for the presence of PNP.

Keywords: Advanced glycation end products, Kynurenine, Blood serum, Diabetes Mellitus, Fluorescence Spectroscopy.
 
         
     
         
         
      Back to previous page